Does Dr. PETER KOWEY have financial conflicts of interest?

Dr. PETER KOWEY (MD) has received a total of $1,142,196 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $1,060,521 in personal promotional payouts (consulting, meals, travel) and $81,675 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. PETER KOWEY?

According to CMS Open Payments data, Dr. PETER KOWEY received funding from JANSSEN RESEARCH & DEVELOPMENT ($191,905), UCB SA ($132,900), and GLAXOSMITHKLINE ($121,300).

Does Dr. PETER KOWEY receive research grants or speaking fees?

Dr. PETER KOWEY has received $1,060,521 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $81,675 in clinical research grants.

DR. PETER KOWEY

MDReal-Time Hydrated

Specialty: Internal Medicine, Cardiovascular Disease

Practice Location: WYNNEWOOD, PA 19096

NPI Number: 1114922945

LIFETIME INDUSTRY VALUE

$1,142,196

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. KOWEY is a verified Internal Medicine, Cardiovascular Disease practitioner based in WYNNEWOOD, PA.

Between 2021 and 2025, Dr. KOWEY had an overall industry promotional and research financial footprint of $1,142,196 as recorded in the federal CMS Open Payments database.

$1,060,521 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$81,675 was allocated to sponsored clinical trials and medical research activities.

Dr. KOWEY's primary funding source is JANSSEN RESEARCH & DEVELOPMENT, which accounts for $191,905 (representing 16.8% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

JANSSEN RESEARCH & DEVELOPMENT

Rank 1

$191,905

16.8%

UCB SA

Rank 2

$132,900

11.6%

GLAXOSMITHKLINE

Rank 3

$121,300

10.6%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.